Novel human α9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity

American Journal of Pathology

Volumn 157, Issue 4, 2000, Pages 1377-1391

  Nguyen, V T ^a   Ndoye, A ^a   Grando, S A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; CARBACHOL; CHOLINERGIC RECEPTOR; DESMOGLEIN; DESMOGLEIN 3 ANTIBODY; IMMUNOGLOBULIN G1; UNCLASSIFIED DRUG; ANTIBODY; CADHERIN; CHRNA9 PROTEIN, HUMAN; DESMOGLEIN 3; DSG3 PROTEIN, HUMAN; IMMUNOGLOBULIN G; NICOTINIC RECEPTOR;

ACANTHOLYSIS; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; BLISTER; CELL ADHESION; CELL MEMBRANE; CONTROLLED STUDY; ESOPHAGUS; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MONKEY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEMPHIGUS VULGARIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RABBIT; REGULATORY MECHANISM; SEQUENCE ANALYSIS; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PEMPHIGUS; PHYSIOLOGY;

ACANTHOLYSIS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; AUTOIMMUNITY; BASE SEQUENCE; CADHERINS; CELL ADHESION; DESMOGLEIN 3; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; KERATINOCYTES; MOLECULAR SEQUENCE DATA; PEMPHIGUS; RABBITS; READING FRAMES; RECEPTORS, NICOTINIC;

EID: 0033623162     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64651-2     Document Type: Article

References (82)

1. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases
2. The pathophysiological significance of non-desmoglein targets of pemphigus autoimmunity. Pemphigus vulgaris and foliaceus patients develop antibodies against keratinocyte cholinergic receptors
3. The 80 KD pemphigus foliaceus antigen extracted from the epidermal envelope fraction is a fragment of desmoglein 1
4. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles
5. Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus particularly Brazilian pemphigus foliaceus
6. Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris
7. Demonstration of antibodies to bovine desmocollin isoforms in certain pemphigus sera
8. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases
9. A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins
10. Autoantibodies to annexins: A diagnostic marker for cutaneous disorders?
11. Anti-FcεRlα autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship
12. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
13. Pemphigus
14. Autoimmunity against desmosomal cadherins in pemphigus
15. Cadherins and blistering skin diseases
16. Defective cell-cell adhesion in the epidermis
17. Making sense of antigens and antibodies in pemphigus
18. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic
19. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice
20. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3)
21. Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies
22. Absorption of pathogenic autoanfibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus
23. Activation of keratinocyte muscarinic acetylcholine receptors reverses pemphigus acantholysis
24. Biological functions of keratinocyte cholinergic receptors
25. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes
26. Choline acetyltransferase, acetylcholinesterase, and nicotinic acetylcholine receptors of human gingival and esophageal epithelia
27. The new pemphigus variants
28. Pemphigus - Diseases of antidesmosomal autoimmunity
29. Pemphigus and bullous pemphigoid
30. Propylbenzilylcholine mustard labels an acidic residue in transmembrane helix 3 of the muscarinic receptor
31. Cloning of the human α9 AChR subunit from normal epidermis and investigations into its physiological role
32. α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells
33. Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis
34. Primary structure and biochemical properties of an M2 muscarinic receptor
35. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes
36. New subtypes of muscarinic acetylcholine receptors
37. Comparative study of autoantigens for various bullous skin diseases by immunoblotting using different dermo-epidermal separation techniques
38. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
39. Human oral epithelial cell culture. II. Keratin expression in fetal and adult gingival cells
40. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease
41. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris
42. Cholinergic modulation of extracellular ATP-induced cytoplasmic calcium concentrations in cochlear outer hair cells
43. The α9 nicotinic acetylcholine receptor shares pharmacological properties with type A gamma-aminobutyric acid, glycine, and type 3 serotonin receptors
44. Calcium and ATP regulation of ion transport in larval frog skin
45. Low-affinity mixed acetylcholine-responsive receptors at the apical membrane of frog tadpole skin
46. Construction of a cDNA library from microdissected guinea pig organ of Corti
47. Expression of the nicotinic acetylcholine receptor subunit, α9, in the guinea pig cochlea
48. Differential expression of the α9 nicotinic acetylcholine receptor subunit in neonatal and adult cochlear hair cells
49. Mammalian nicotinic receptors with α7 subunits that slowly desensitize and rapidly recover from α-bungarotoxin blockade
50. Developmental expression of α9 acetylcholine receptor mRNA in the rat cochlea and vestibular inner ear
51. The keratinocyte cholinergic system with acetylcholine as an epidermal cytotransmitter
52. Thymoma, thymic hyperplasia, thymectomy and autoimmune diseases
53. Pemphigus associated diseases and induced pemphigus
54. 2+ signalling
55. Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line
56. Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line
57. Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes
58. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes
59. Acetylcholine-induced phosphorylation in isolated outer hair cells
60. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice
61. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris
62. Regulation of E cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma
63. Role of α9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation
64. Vesicle formation and follicular root sheath separation in mice homozygous for deleterious alleles at the balding (bal) locus
65. Pemphigus vulgaris antibody identifies pemphaxin: A novel keratinocyte annexin-like molecule binding acethylcholine
66. A pool of disease-causing pemphigus vulgaris IgGs contains an autoantibody to pemphaxin, a calcium-dependent keratinocyte annexin-like molecule that can be unregulated by methylprednisolone
67. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II
68. Directed actin polymerization is the driving force for epithelial cell-cell adhesion
69. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid
70. Autoreactive cytotoxic T lymphocytes in pemphigus and pemphigoid
71. Pemphigus and pemphigoid epidermocytes interfere with interleukin cascade reactions
72. Immune modulation in pemphigus vulgaris: Role of CD28 and IL-10
73. Correlation of antibodies in skin and serum with disease severity in pemphigus
74. A case of pemphigus vulgaris improved by cigarette smoking
75. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: A review of 13 cases
76. The action of nicotinamide on neuromuscular transmission
77. Acetylcholine release and choline availability in rat hippocampus: Effects of exogenous choline and nicotinamide
78. Bioelectrocatalytical studies of the effect of some pharmaceuticals on the acetylcholinesterase activity